$BKV

BKV Prices Upsized $500M 1.625% Convertible Notes Due 2031

BKV priced a $500M offering of 1.625% convertible senior notes due 2031, with an option for $75M more. The notes bear 1.625% interest, mature Oct 15, 2031, and have an initial conversion price of ~$31.93/share, a 32.5% premium to the $24.10 NYSE close on Sept 9, 2026. Estimated net proceeds are ~$481.8M, with ~$56.3M for capped calls and ~$35.0M for share repurchases.

Original reporting
Published Sep 10, 2026, 12:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 4:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BKV Prices Upsized $500M 1.625% Convertible Notes Due 2031 — source image
Decision brief

The 30-second read

$BKVNeutralHigh
01

Why it matters

The capital raise strengthens liquidity but introduces conversion dilution risk; investors should monitor share repurchase plans.

02

Market read

Primary disclosure of a large capital raise for a US‑listed mid‑cap financial firm.

03

What to watch

Impact of capped call transactions and conversion premium on future dilution dynamics.

Relevance 9/10Novelty 9/10Timing: today

Background

BKV Corp filed an 8‑K on Sep 10, 2026 announcing the convertible note offering.

Company-level read

Ticker impact

$BKVNeutralHigh confidence
Context

BKV Corp priced an upsized $500M 1.625% convertible senior notes due 2031, a fresh capital raise disclosed in an 8‑K filing.

Expected impact

Short‑term price pressure from dilution risk, followed by stabilization as proceeds are deployed.

Evidence & confidence

Large primary market raise is material; market will price in dilution and cash infusion effects.

Market effects

May influence other mid‑cap financial issuers considering convertible financing.

Limited to US equity markets; no broader regional effect.

Low global relevance beyond investors tracking US convertible markets.

Counterpoint

Potential overvaluation risk if proceeds are not efficiently deployed, leading to share price decline.

Key entities

  • BKV Corp

    Issuer of the convertible senior notes.

Related articles

$BKVMedAI 9/10

How Investors May Respond To BKV (BKV) Shelf Registration After Q2 Outperformance

BKV Corporation filed a $140.17M shelf registration for 5.32M shares after Q2 earnings beat expectations, with revenue and EPS exceeding estimates. The company's integrated natural gas and carbon capture model drove strong performance, but investors should consider potential dilution and high debt levels. BKV projects $1.6B revenue and $144.1M earnings by 2029, requiring 18.1% yearly revenue growth.

$BKVMedAI 8/10

BKV (BKV) Q2 2026 Earnings Call Transcript

BKV Corporation reported Q2 2026 adjusted EBITDAX of $142 million and adjusted net income of $51 million, and increased full-year upstream production guidance to a midpoint of 950 MMcf/d. Total cash costs fell 10% QoQ. Power generation rose, and net debt was $1.1 billion with liquidity of $840 million. BKV also raised 2026 strategic power capital guidance to $400-$475 million.

$BKVMed

BKV (NYSE:BKV) Beats Expectations in Strong Q2 CY2026

BKV, a natural gas producer, reported Q2 CY2026 results. Revenue rose 44.6% year on year to $465.5 million, beating Wall Street estimates by 27.4%, and GAAP profit was $0.67 per share above consensus. Adjusted EBITDA margin was 39.1%, and free cash flow was $22.9 million (4.9% margin). Shares rose about 3% to $23.69 after the report.

$BKVMed

BKV Corp (BKV): Results of Operations and Financial Condition

BKV Corp (BKV) filed an SEC Form 8-K — Results of Operations and Financial Condition. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2026 BKV CORPORATION (Exact name of registrant as spe